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The brain is made up of trillions of synaptic connec-
tions that together form neural networks needed for
normal brain function and behavior. SLM2 is a mem-
ber of a conserved family of RNA binding proteins,
including Sam68 and SLM1, that control splicing of
Neurexin1-3 pre-mRNAs.Whether SLM2 affects neu-
ral network activity is unknown. Here, we find that
SLM2 levels are maintained by a homeostatic feed-
back control pathway that predates the divergence
of SLM2 and Sam68. SLM2 also controls the splicing
of Tomosyn2, LysoPLD/ATX, Dgkb, Kif21a, and
Cask, each of which are important for synapse func-
tion. Cortical neural network activity dependent on
synaptic connections between SLM2-expressing-
pyramidal neurons and interneurons is decreased in
Slm2-null mice. Additionally, these mice are anxious
and have a decreased ability to recognize novel
objects. Our data reveal a pathway of SLM2 homeo-
static auto-regulation controlling brain network ac-
tivity and behavior.
INTRODUCTION
Alternative splicing expands the coding information in the
genome many fold. More than 95% of human genes encode
alternative mRNAs, and on average each human gene makes
11 different mRNAs (Djebali et al., 2012). Alternative splicing is
controlled by a large set of ubiquitous, as well as tissue-specificCell Repor
This is an open access article undRNA binding proteins and is functionally important in the
brain and across development (Kalsotra and Cooper, 2011).
Genetic knockout of some splicing regulators can cause cata-
strophic phenotypic effects on brain development (Gehman
et al., 2012), and even subtle defects in splice factors have
been linked with diseases such as autism and neurodegenera-
tion (Voineagu et al., 2011). SLM2 is a tissue-specific RNA bind-
ing protein expressed at high levels in the brain and is related to
the Sam68 and SLM1 RNA binding proteins following a gene
triplication 500 million years ago. Both SLM2 and Sam68 bind
to UA-rich target sequences (UAAA and UUAA) (Feracci et al.,
2016). Analysis of the transciptome of whole mouse brain (Ehr-
mann et al., 2013) and whole hippocampus (Traunm€uller et al.,
2016) showed that SLM2 regulates skipping of the Neurexin1-3
AS4 exons and a cassette exon within Tomosyn-2 (Stxbp5l).
The Neurexin 1-3 proteins are important for synapse forma-
tion, maturation, and function in the brain, where they play a crit-
ical role in stabilizing the trans-synaptic complex, and help
generate and maintain communication at both glutamatergic
and GABA (gamma-aminobutyric acid)-ergic synapses (Reiss-
ner et al., 2013). Tomosyn-2 is a syntaxin 1A binding protein.
Mutations within the human Neurexin1 gene are associated
with neuropsychiatric conditions including developmental delay,
epilepsy, autism, and schizophrenia (Harrison et al., 2011; Raba-
neda et al., 2014; Reichelt et al., 2012; Reissner et al., 2013;
Schaaf et al., 2012). Mutations within the human Neurexin3
gene are involved in obesity and addiction (Aoto et al., 2015).
Deletion of the mouse Neurexin1 gene causes electrophysiolog-
ical defects, changes in motor learning and acoustic startle reac-
tivity that correlate with schizophrenia (Etherton et al., 2009),
changed motor activity in novel environments (Grayton et al.,
2013), and impaired neurotransmitter release (Pak et al., 2015).ts 17, 3269–3280, December 20, 2016 ª 2016 The Author(s). 3269
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. SLM2 Controls Regional Splicing of a Subset of Genes Involved in Synaptic Function
(A) Schematic of hippocampus showing SLM2 expression within the CA1–CA4 regions (shown in brown) but not the dentate gyrus (shown in gray).
(B–D) Splicing patterns between the dentate gyrus/CA4 and CA1–CA3 regions of wild-type mice of (B) Neurexin1 AS4, (C) Neurexin2 AS4, and (D) Tomosyn2.
Lower panels are agarose gels (+, exon inclusion product; –, exon skipping product). Upper panels show average data with individual samples shown in the
agarose gel indicated as red dots. Error bars represent SEM.
(E) Scatterplot showing splicing changes between the CA1–CA3 region of wild-type and Slm2 KO mice detected by RNA-seq. The scatterplot shows expected
percentage in (E(PSI)) for wild-type and Slm2-null mice in the CA1–CA3 region of wild-type (WT) and Slm2-null (KO) mice detected by RNA-seq using MAJIQ
(Vaquero-Garcia et al., 2016). Splicing changes that were validated by RT-PCR are named and arrowed. High-confidence splicing changes (P(jDPSIj > V) >95%)
are marked in dark red for a predicted change of V = 20%, and dark yellow for a predicted change of V = 10% . All other quantified splice changes are in yellow
(21,280 events examined). Dashed lines indicate DPSI of +10%.The brain is made up of trillions of synaptic connections that
together form neural networks that underpin whole brain function
and behavior (Eroglu and Barres, 2010). Whether SLM2 expres-
sion impacts activity of these neural networks is unknown, but
selective engineered changes in two SLM2-target Neurexin3
AS4 andNeurexin1 AS4 exons affect individual synapse function
(Aoto et al., 2013; Traunm€uller et al., 2016). SLM2-dependent
post-synaptic responses and plasticity within CA1 pyramidal
neurons can also be rescued by heterozygote deletion of the
Neurexin1 AS4 exon, although individual SLM2-regulated exons
are likely to have different functional effects (Aoto et al., 2013;
Traunm€uller et al., 2016).
Previous work showed that SLM2 expression drives regional
splicing patterns across forebrain-derived structures, and that
within the hippocampus SLM2 is expressed within the CA1–
CA4 regions but excluded from the dentate gyrus (Ehrmann
et al., 2013; Iijima et al., 2011, 2014; Traunm€uller et al., 2014).
Here, we find that the previously known splicing targets of
SLM2 have reciprocal splicing patterns between CA1–CA3 and
the dentate gyrus according to SLM2 expression levels. We
hence searched for splicing changes between just the CA1–
CA3 regions of wild-type and Slm2-null mice, so that any such
differences would not be diluted by the splicing patterns in den-
tate gyrus cells that do not express Slm2. Through this analysis,
we double the validated number of known SLM2-target exons
and identify a potent homeostatic feedback control pathway
that maintains stable Slm2 gene expression levels. Our data3270 Cell Reports 17, 3269–3280, December 20, 2016support a model where this feedback control pathway has
evolved to maintain stable neural network activity and associ-
ated patterns of mouse behavior via moderating splicing control
of synaptic isoforms.
RESULTS
Known SLM2-Target Exons Are Differentially Controlled
between theDentateGyrus andCA1–CA3Regions of the
Hippocampus
Since SLM2 protein spatially controls splicing patterns over
different brain regions (Ehrmann et al., 2013), we predicted that
SLM2 expression might regionally control splicing within the
hippocampus between the CA1–CA4 and the dentate gyrus,
corresponding to endogenous patterns of protein expression
(shown schematically in Figure 1A). We tested this prediction
by analyzing regional splicing patterns of known SLM2-target
exons between the CA1–CA3 and the CA4/dentate gyrus
(because the CA4 region interdigitates within the dentate gyrus,
it was difficult to dissect these manually). Supporting our predic-
tion, significantly higher levels of skipping of Neurexin1 AS4,
Neurexin2 AS4, and Tomosyn2 exons were observed within
the CA1–CA3 regions (Figures 1B–1D) that express higher levels
of SLM2 protein (Ehrmann et al., 2013).
Previous transcriptome-wide screens have identified only a
small number of SLM2-targets (Ehrmann et al., 2013; Traunm€ul-
ler et al., 2016). However, the above regional splicing data also
Figure 2. SLM2 Protein Auto-regulates the 30 End of Its mRNA
(A) Genomic structure of the mouse Slm2 gene, and a variant EST AK014353 that has two additional downstream exons downloaded as a screenshot from the
UCSC genome browser (Rosenbloom et al., 2015). Exons are numbered 1–11: notice that the Refseq gene has nine annotated exons, and mRNA AK014353,
which is transcribed from the same locus, has 11 annotated exons.
(legend continued on next page)
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predicted that it would be easier to detect splicing changes
within the Slm2 knockout hippocampus by comparing CA1–
CA3 transcriptomes, rather than comparing a mixture of dentate
gyrus and CA1–CA3 transcriptomes. We thus carried out
specific RNA sequencing (RNA-seq) analysis of the CA1–CA3
regions of the hippocampus from wild-type and Slm2 knockout
(KO) mouse CA1–CA3 regions (GEO accession number
GSE70895). Although we still found splicing changes in a rela-
tively small number of exons in theSlm2KOmouse, we validated
nine targets by RT-PCR, five of which had not previously been
described, thus doubling the number of known SLM2 target
exons (Figure 1E).
Mouse SLM2 Protein Regionally Controls Its OwnmRNA
Processing across the Brain
We observed a decreased inclusion of Slm2 exon 9 in the Slm2
KO compared to the wild-type mouse background (Figure 1E).
Note Slm2 exon 2 is also missing from the Slm2 KO transcrip-
tome, as this exon was deleted to make the Slm2 knockout).
The overall gene structure of mouse Slm2 is illustrated in Fig-
ure 2A (Rosenbloom et al., 2015). Visual analysis of the RNA-
seq reads mapping to Slm2 exon 9 indicated a discontinuity in
the RNA-seq profile of wild-type but not Slm2 KO mice (Figures
2B and 2C, with the position of discontinuity shown as an
asterisk). While exon 9 is annotated as the terminal exon of the
Slm2 gene, there is also mRNA sequence evidence (Rose-
nbloom et al., 2015) for two additional downstream non-coding
exons that are spliced onto an internal 50 splice site within the
Slm2 exon 9 (Figures 2A and 2B). The two Slm2 exons down-
stream of exon 9 are annotated as exons 10 and 11, and the re-
sulting downstream alternative mRNA 30 end as Slm2 alternative
end 2 (Figure 2B). The position of the discontinuity in RNA-seq
reads within the wild-type mouse corresponds exactly to the
location of the alternative 50 splice site that leads to creation of
Slm2 alternative 30 end 2 (Figure 2C). The RNA-seq reads corre-
sponding to Slm2 mRNA exons 10 and 11 were more abundant
in the wild-type mouse traces compared with the Slm2 knockout
mouse (Figure 2B).
SLM2 Regulates Its Own mRNA via a Concentration-
Dependent Feedback Loop
Confirming these downstream exons are also physically spliced
onto Slm2 mRNA, RT-PCR analysis using a forward primer in
exon 8, and reverse primers in exon 9 (downstream of the 50
splice site) and exon 11 detected two products within the mouse
brain (Figure 2D). Parts of the brain known to express higher
levels of SLM2 protein (Ehrmann et al., 2013) also express
more Slm2 alternative 30 end 2 (these were the hippocampus,(B) CA1–CA3 RNA-seq patterns at the downstream end of the Slm2 gene from S
additional exons 10 and 11 in the wild-type mouse generate Slm2 alternative end
the UCSC genome browser (Rosenbloom et al., 2015).
(C) RNA-seq traces predict use of the internal splice site in Slm2 exon 9 in wild-typ
is indicated by a red asterisk).
(D) Representative agarose gel showing patterns of alternative Slm2 30 ends in d
(E) Mouse brain structures analyzed for mRNA processing patterns.
(F) Mean percentage selection of Slm2 alternative end 2 in different brain structur
out using GraphPad, using RT-PCR data collected from capillary gel electrophor
See also Figure S1.
3272 Cell Reports 17, 3269–3280, December 20, 2016cortex, basal ganglia, thalamus, and hypothalamus) (Figures
2D–2F). Physiological selection of Slm2 alternative 30 end 2
within each brain structure was decreased from Slm2 knockout
animals compared with wild-type (Figures 2E and 2F).
PhastCons analysis (Rosenbloom et al., 2015) shows that
exons 9–11 of the Slm2 gene are within highly conserved regions
of the mouse genome (Figure 2B). Human, mouse, and chicken
SLM2 genes have an identical arrangement of exons (with two
alternative 30 ends created by alternative utilization of a 50 splice
site within exon 9, Figure 3A). Each genome region also con-
tainedmultiple UAAA and UUAA sequences that could be bound
by SLM2. In each case, these sequences were specifically
depleted from the portion of exon sequence immediately up-
stream of the exon 9 internal 50 splice site that becomes spliced
onto the downstream 30 UTR exons. Tissue-specific use ofSLM2
alternative end 2 in the brain and testis, where SLM2 is highly
expressed, was also detectable within RNA-seq reads from
humans and chickens so must predate the divergence of the
lineages leading to mammals and birds (Figures S1A–S1E).
To test whether selection of human SLM2mRNA alternative 30
end 2 could be induced by increased SLM2 protein expression,
we engineered a stable human HEK293 cell line that expresses a
human SLM2-FLAG fusion protein in response to tetracycline
addition. Western blots showed that expression of SLM2-
FLAG protein within this engineered cell line was efficiently
induced after 24 hours of tetracycline treatment (Figure 3B).
Since formation of SLM2 alternative end 2 involves the splicing
of two downstream non-coding exons onto the SLM2 mRNA,
we postulated that SLM2 mRNA would be a substrate for
nonsense-mediated decay (NMD). RT-PCR was used to detect
endogenous human SLM2 mRNAs (Figure 3C). Consistent with
SLM2 mRNAs with alternative end 2 being an unstable mRNA
population that is normally targeted for destruction through
nonsense-mediated decay, human SLM2 mRNA isoforms with
alternative end 2 were induced by overexpression of SLM2 pro-
tein, and strongly stabilized by the addition of cycloheximide
(Figure 3C, compare lanes 3 and 6). Only low levels of SLM2
mRNA isoforms with alternative end 2 could be detected in the
absence of cycloheximide, even after overexpression of SLM2
protein (Figure 3C, compare lines 5 and 6), although SLM2
alternative end 1 was efficiently detected.
Sam68 Protein Also Regulates Itself via an NMD
Pathway
The above data showed that SLM2 protein auto-regulates its
expression levels through an NMD pathway that is closely linked
to splicing selection of an alternative 30 end within the terminal
coding exon of the Slm2 gene. However, given the low levelslm2 KO and wild-type mice aligned to the mouse genome: notice the use of
2. Single representative RNA-seq tracks are shown here as a screenshot from
emice only (the position of the exon 9 internal 50 splice site in the RNA-seq trace
ifferent brain structures from wild-type and Slm2 KO mice.
es from wild-type and Slm2-null mice. Statistical analyses (t tests) were carried
etic analysis of three independent replicates. Error bars represent SEM.
Figure 3. Alternative 30 End Processing of SLM2 mRNA Is Modulated in Response to Increasing SLM2 Protein Concentrations Leading to
mRNA Instability
(A) Distribution of potential binding sites for SLM2 protein (purple arrowheads) in the downstream portion of the SLM2 gene of human, mouse, and chicken. Exons
are shown as boxes. The canonical mRNA 30 end is shown in red with its normal poly(A), and the alternative 30 end (AS) in blue.
(B) Western blot showing tetracycline-induction of SLM2-flag tagged protein within a stable HEK293 cell line as compared to a control cell line (made with empty
pCDNA3 vector), detected using a-FLAG antibodies (a-actin used as a loading control).
(C) Agarose gel showing induction of SLM2 alternative end 2 is induced by tetracycline treatment and stabilized by cycloheximide treatment.
See also Figure S2.of expression of endogenous human SLM2 protein in HEK293
cells, particularly relative to the induced SLM2-FLAG protein,
we were unable to monitor whether this feedback pathway
reduced the expression of endogenous human SLM2 protein,
or see consistent stabilization after small interfering RNA (siRNA)
depletion of the UPF1 protein that is involved in mRNA surveil-
lance and degradation (data not shown). We thus examined
the more generally expressed Sam68 locus on the UCSC
genome browser (Rosenbloom et al., 2015) and found a similar
arrangement of downstream non-coding exons that are spliced
onto a proportion of Sam68 mRNAs to produce similar alterna-
tive ends to SLM2 (annotated as 1 and 2 on Figure S2A).
We therefore constructed a stable HEK293 cell line in which a
SAM68-FLAG fusion protein was expressed in response to tetra-
cycline addition. Induction of Sam68 protein and addition of
cycloheximide strikingly increased the levels of endogenous
Sam68 mRNA alternative 30 end 2 (Figure S2B, compare lanes
5 and 6). Addition of cycloheximide also stabilized endogenous
Sam68 mRNA terminating in alternative end 2 in the control
cell line that did not overexpress Sam68 protein, albeit at lowerlevels (Figure S2B, compare lanes 2 and 3). Supporting these
data, we also observed strong stabilization of the endogenous
Sam68 alternative end 2 transcript within the Sam68-overex-
pressing cell line after siRNA depletion of UPF1, in parallel
to similar stabilization of the known NMD substrate U2AF35
isoform c within the same cells (Figures S2C–S2F) (Pacheco
et al., 2004). The higher level of endogenous expression of
Sam68 within HEK293 cells also enabled us to monitor the effect
of overexpressed Sam68-FLAG protein on endogenous Sam68
expression. Consistent with the Sam68 feedback control
pathway also operating at the protein level, we observed a
decreased level of endogenous Sam68 protein on stable expres-
sion of Sam68-FLAG by western blotting (Figure S2G).
These auto-regulatory pathways identified for Slm2 and
Sam68 are analogous to the recently described cross-regulatory
splicing control of Slm1 by SLM2 (Traunm€uller et al., 2014). We
also found that mouse Slm1 splicing is under regional control
across the mouse brain by SLM2, similar to the pattern of
Slm2 auto-regulation (Figures S3A and S3B). However, we de-
tected only very low levels of Sam68 alternative end 2 in theCell Reports 17, 3269–3280, December 20, 2016 3273
Figure 4. SLM2 Expression Controls
Splicing of a Wider Panel of Genes Involved
in Synaptic Function
(A–D) Splicing patterns within wild-type (WT) and
Slm2-null (KO) CA1–CA3 regions for exons in the
(A) Kif2la, (B) DGKB, (C) CASK, and (D) LysoPLD/
ATX genes.
(E and F) Splicing patterns within the CA1–CA3
and dentate gyrus (DG)/CA4 regions of wild-type
mice for exons in the (E) Kif2la and (F) LysoPLD/
ATX genes.
In (A)–(F) splicing inclusion patterns were analyzed
in triplicate mice by RT-PCR, followed by agarose
and capillary gel electrophoresis. Scatterplots
show data from three independent biological
replicates from each genotype as percentage
splicing inclusion (PSI). Statistical significances
were measured using t tests (GraphPad prism).
For each regulated exon, agarose gel analysis
of a single wild-type and Slm2 knockout sample
from the three biological samples quantitated are
shown (these samples shown are red points in
the scatterplot). The exon inclusion product is
labeled +, and exon skipped product –.
(G) Minigene analysis of wild-type (lanes 1–3)
and mutant Kif21a (lanes 4–6) in which there is
complete mutation of UWAA sequences flanking
the Kif21a exon with the exception of those
just around the branchpoint. Upper panel shows
capillary gel electrophoretogram. Lower panel
shows bar chart including averaged data from at
least three independent biological samples for
each transfection. Error bars represent SEM.
See also Figure S3.wild-type and Slm2-null mouse hippocampus—most of the
Sam68 mRNAs used alternative end 1 (Figure S2C). Analysis of
Sam68 knockout mouse brain RNA showed no change in Slm2
splicing profile in different Sam68 genotypes, indicating that
Slm2 feedback control is not cross-regulated by Sam68 in the
mouse brain (Figures S3D and S3E).
SLM2 Expression Controls Splicing of a Wider Panel of
Genes Implicated in Synaptic Function
Strikingly, apart from the auto-regulatory Slm2 splicing event, the
other significant splicing changes identified by RNA-seq between
wild-typeandSlm2knockoutCA1–CA3alsoaffectedproteinswith
known rolesat thesynapse (TableS1).These included the fourpre-
viously identified SLM2 targets: Neurexin1-3 AS4 exons and an
exon in the Tomosyn-2gene (also known asSTXBP5L, orSyntaxin
Binding Protein 5 like). These four targets had strongly increased
percentage splicing inclusion (PSI) in the Slm2 knockout back-
ground (Figure 1D) (Ehrmann et al., 2013; Traunm€uller et al.,
2016). Newly discovered cassette exons displaying increased
splicing inclusion in the Slm2 knockout background were also
experimentallyverifiedwithin theDgkb (encoding theDiacylglycer-
olkinasebetasubunit) andKif21a (encodingkinesin familymember
21a) genes (Figures 4A and 4B).Slm2 knockoutmice also showed
decreased inclusion of cassette exons within the LysoPLD/ATX
gene (Lysophospholipase D/Autotaxin, also known as ENPP2)
and the Cask gene (encoding Calcium/Calmodulin Dependent
Serine Protein Kinase) (Figures 4C and 4D).3274 Cell Reports 17, 3269–3280, December 20, 2016The SLM2-controlled alternative exons in the Kif21a and Cask
genes have adjacent alternative exons, resulting in more com-
plex patterns of products after RT-PCR (Figures 4A and 4C).
Kif21a is a direct target of both SLM2 andSam68, since transfec-
tion of a Kif21a minigene containing the regulated exon and
flanking intron sequences into HEK293 cells along with either
SLM2 or Sam68 resulted in increased exon skipping compared
to co-expression of GFP (Figure 4G, lanes 1–3). Splicing of
both Kif21a and LysoPLD/ATX was also differentially regulated
between the CA1–CA3 and dentate gyrus/CA4 (Figures 4E and
4F), showing these exons are regionally controlled within the
hippocampus.
Analysis of the mouse genome sequence revealed UAAA
and UUAA sequences that could be recognized by SLM2
and Sam68 proteins flanking the newly identified target exons
(Feracci et al., 2016; Rosenbloom et al., 2015), similar to
those that flank the previously known Neurexin1-3 AS4 and
Tomosyn-2 cassette exons (Figure 5A). We confirmed binding
of SLM2 to these UWAA-rich sequences by gel shift (Fig-
ure 5B). In comparison, no shift was observed for the negative
control RNA probe, representing an adjacent region of
the Kif21a intron (Figure 5B). At least some of these sites
are functional in splicing control, since mutation of the
UWAA binding sites flanking the Kif21a exon minigene totally
blocked splicing repression by SLM2-GFP and Sam68-GFP
proteins in co-transfected HEK293 cells (Figure 4G, lanes
4–6).
Figure 5. Splicing Targets Controlled by
SLM2 within the CA1–CA3 Regions Have
Flanking Intron Sequences Containing
UWAA Motifs
(A) Distribution of UWAA sequences flanking
exons that change splicing patterns within the
Slm2 KO mouse. A 1-kb window of the mouse
genome is shown, with the SLM2 regulated exon
in red, surrounded by flanking intron sequence.
For each genomic region, the distribution of UAAA
and UUAA repeats are shown in purple.
(B) Potential Sam68 and SLM2 target sequences
were cloned into pBluescript and transcribed
into radiolabelled RNA probes. RNA-protein in-
teractions were confirmed by gel shifts (right
panels) with RNA sequences shown at the left
(UWAA binding sites are highlighted in red for
UAAA, and yellow for UUAA. Note a number of
UAAA and UUAA sites are overlapping).
See also Figure S3.SLM2 Protein Is Important for Synaptic Connectivity in
the Mouse Hippocampus and Dentate Gyrus
Immunofluorescent localization within the hippocampal strata
radiale (sr), pyramidale (sp), and oriens (so), indicated that the
majority of parvalbumin (abbreviated PV) positive interneurons
within CA3 express nuclear SLM2 protein (arrowheads in Fig-
ure 6A). Nearly all of the larger, excitatory glutamatergic pyrami-
dal cells in the CA3 fields of the hippocampus also strongly
express SLM2 protein, identified by their large nuclei, and by
their location in the stratum pyramidale. SLM2/NPNF (non-phos-
phorylated neurofilament) positive pyramidal cells are indicated
by arrowheads in Figure 6B. Very few large nuclei, identified by
DAPI counterstaining, were completely SLM2 protein negative
(a SLM2 negative/NPNF positive pyramidal cell is indicated
by an asterisk in Figure 6B). Instead, negatively staining nucleiCell Reportswere generally small and mostly be-
longed to glial cells, but could also be
interneuronal or small pyramidal cell
nuclei. These data are also consistent
with results from within the CA1 subfield
(Iijima et al., 2014).
Synaptic interactions between gluta-
matergic pyramidal cells and fast spiking
(FS) inhibitory interneurons generate
network activity in vivo called g (gamma)
oscillations within cortical microcircuits
(Figure 6C) (Mann et al., 2005). Since pat-
terns of g oscillation can be disrupted
in schizophrenic patients (Basar-Eroglu
et al., 2007) and deletions of the human
Neurexin1 gene are associated with
schizophrenia (Gauthier et al., 2011), we
tested whether SLM2 protein controlled
the activity of these microcircuits. Extra-
cellular LFP (local field potential) record-
ings of g oscillations were conducted in
stratum radiatum of the CA3 subfield ofthe hippocampus following the bath application of 50 nM kai-
nate, and the induced oscillation was analyzed (n = 4 SLM2
knockout mice and five wild-type littermates) (Figure 6D). At
concentrations of 50 nM kainate, the power of g oscillations in
CA3 was significantly larger in slices from wild-type (WT) mice
than in slices from Slm2 knockout (KO) mice. Maximal integral
power (20–80 Hz) for WT slices was 1,013.7 ± 342.6 mV2/Hz
(n = 12 slices) and in slices from the Slm2 KO mice 251.9 ±
34.2 mV2/Hz (n = 10 slices; p < 0.05). The mean peak frequency
of CA3 g oscillations was not significantly different at con-
centrations of 50 nM kainate (WT 33.1 ± 1.6 Hz versus Slm2
KO 36.9 ± 2.6 Hz; p > 0.05).
Since the Neurexin genes are associated with epilepsy, we
also monitored neuronal network excitability in the Slm2-null
compared to wild-type CA3 regions at higher concentrations of17, 3269–3280, December 20, 2016 3275
Figure 6. Absence of SLM2Protein Disrupts
Hippocampal g Rhythms
(A) Confocal detection of SLM2 protein (red) in
large nuclei in the pyramidal layer (sp) of the hip-
pocampal sections and in most (arrowheads), but
not all (asterisks), PV expressing interneurons of
the hippocampus. so, stratum oriens of hippo-
campus; sr, stratum radiatum. Scale bar, 50 mm.
(B) SLM2 positive nuclei (red) co-localized with
non-phosphorylated neurofilament (abbreviated
NPNF, green) immunoreactivity in pyramidal neu-
rons (arrowheads) of the CA3 hippocampal region.
A rare NPNF positive/SLM2 negative pyramidal
neuron is indicated by an asterisk. Scale bar,
50 mm.
(C) Network interactions between pyramidal and
interneuron cells are mediated by connecting
axons that carry excitatory and inhibitory signals,
to generate patterns of g oscillations in the brain.
FS parvalbumin (PV) containing interneurons pro-
vide robust aminobutyric acid (GABA) receptor-
mediated inhibition to the perisomatic regions of
pyramidal neurons. In turn, pyramidal neurons
feedback onto these FS/PV interneurons supply-
ing phasic excitation that is mainly through
receptor-mediated excitatory post-synaptic po-
tentials.
(D) (Di) Example local field potential traces
showing oscillatory activity in the CA3 subfield
of the hippocampus from littermate wild-type
(WT; red) and SLM2/ null (KO; blue) mice. (Dii)
Example power spectrum composed from 60-s
epoch of local field potential activity from WT (red)
and KO (blue) slice. (Diii) Dot plot showing indi-
vidual data points for peak frequency (top) and
area power (bottom) of g oscillations in CA3 in
WT (red) and KO (blue). Each dot represents a
recording from a single slice (ten slices analyzed
across four SLM2-null mice and 12 slices across
five wild-type mice). The horizontal bars represent
group averages. Note that in the CA3 region, only
the area power (bottom) is changed significantly
(*p < 0.05, Student’s t test) when slices from WT
and KO mice are compared. Peak frequency and
power values were obtained from power spectra
generated with Fourier analysis in the Axograph X
software package (Kagi). Power for a given fre-
quency band was determined as the area under
the peak in the power spectra between 20 and
80 Hz for g frequency oscillations. All values
are given as the mean ± SE where distributed
normally; otherwise, data are expressed as the median (interquartile range). Power spectra were constructed offline from digitized data (digitization frequency,
10 kHz), using a 60-s epoch of recorded activity. Experiment and data analysis was performed by an individual who was blind to the origin of the slices.
See also Figures S4 and S5.kainate (200 nM). In wild-type mice, high amplitude burst dis-
charges (epileptiform activity) co-existed with ongoing g oscilla-
tions. However, this epileptiform activity was reduced by 50%
in Slm2 knockout mice brain slices compared to wild-type (Fig-
ure S4). Only 25% Slm2 KO mouse slices exhibited epileptiform
activity. This suggests the impairment of synaptic function and/or
expression of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) receptors on PV interneurons in the Slm2 KO.
Immunofluorescence analysis showed that SLM2 protein also
localized within pyramidal and interneuron cell types within3276 Cell Reports 17, 3269–3280, December 20, 2016layers II and III of the entorhinal cortex (abbreviated EC, Figures
S5A and S5B). Bath application of kainate (200–400 nM) pro-
duced persistent g frequency oscillation with the largest power
of activity exhibited in the superficial layers (II/III) of the medial
entorhinal cortex (mEC). In the presence of 200 nM kainate,
the power of mEC g oscillations was significantly larger in the
WT slices than slices obtained from Slm2 KO mice (Figure S5C).
Maximal integral power for WT slices was 341.3 ± 85.5 mV2/Hz
(n = 9 slices) and in slices from the Slm2 KO mice 44.3 3 ±
16.9 mV2/Hz (n = 9 slices; p < 0.05). In contrast to the
Figure 7. Increased Anxiety and Impaired
Memory in Slm2-Null Mice
(A) Slm2-null and wild-type mouse performance
during an elevated plus test (n = 13 wild-type and
12 Slm2-null mice).
(B) Examples of path tracks from Slm2 KO (blue)
and wild-type (red) mice during habituation (top)
and test trial (bottom) in the open field. Schematic
draw of familiar and novel objects positions in the
arena (gray). Spots of color correspond to FO (left)
and NO (right) positions. Note, Slm2 KO show the
same amount of exploration toward FO and NO,
while wild-type mice show the normal preference
toward NO.
(C and D) Graphs reporting distance traveled (C)
and time spent in center versus periphery (D) of the
test arena during the open-field task. n = 7 Slm2
KO and 9 wild-type mice. Error bars represent
SEM.
(E) Time in exploration toward the novel object was
significantly reduced in Slm2 KO mice as
compared to littermate wild-type controls. Graph reports discrimination index values measured as time in contact with novel object/time in contact with the two
objects during test trial in object recognition task. Of note, a preference index above 50% indicates that the novel object was preferred to familiar one andmeans
intact discrimination memory; preference index of 50% indicates that mice spent the same amount of time in exploration of the two objects, which indicates
memory impairment. n = 10 mice per genotype.
See also Figure S6.hippocampus, the mean peak frequency of EC g oscillations
was also significantly different at this concentration of kainate
(WT 55.3 ± 4.0 Hz versus Slm2 KO 36.7 ± 4.9 Hz; n = 9 slices,
p < 0.05).
Slm2 KO Mice Display Increased Anxiety and Impaired
Memory Abilities
Since both neurexins and aberrant patterns of cortical g oscilla-
tion activity have been implicated in the sensory and perceptual
deficits observed in psychiatric disease, we tested a measure of
sensory coding processes in the Slm2-null mouse. No difference
betweenwild-typemice andSlm2 knockoutmicewere observed
in a prepulse inhibition test (PPI), which measures sensimotor
gating, reflecting the ability of the animals to integrate and inhibit
sensory and information (females: prepulse tone p < 0.0001, ge-
notype p = 0.678, interaction p = 0.6427. Males: pre-pulse tone
p < 0.0001, genotype p = 0.053, interaction p = 0.5911) (Figures
S6A and S6B).
Last, we probed Slm2-null mice for behavioral and cognitive
functions. Elevated maze and open-field tasks were used to
assess anxiety-related behavior. Time spent in the open arms
of the elevated maze was slightly but not significantly (p >
0.05) reduced in Slm2 knockout mice (82.77 ± 57) as compared
to wild-type controls (99.76 ± 69), thereby suggesting increased
anxiety behavior in thesemice (Figure 7A). To further explore this
possibility, mice were subjected to an open-field test. In this
task, we used as indexes of anxiety behavior both general
exploratory activity of mice and the time they spent in center
versus periphery of a squared arena. As shown in Figures 7B
and 7C, Slm2 knockout mice traveled shorter distance as
compared to wild-type (average distance: 2,233 ± 350 cm in
Slm2 knockout mice and 3,464 ± 189 cm in WT mice; one-way
ANOVA: F1,14 = 10,83; p = 0.005). This reduced motor activity
was not due to a locomotor defect, as assessed by rotarodtest (Figures S6C and S6D). Also, we found that Slm2-null mice
spent less time in the central region of the arena (Figures 7C
and 7D) as compared to wild-type (time spent in center: 11%
in Slm2 knockout mice and 21% in wild-type mice; one-way
ANOVA: F1,7 = 15,32; p = 0.005). Together, these data indicate
that Slm2-null mice display increased anxiety-related behaviors.
Reduction in cortical g oscillations has been associated with
defects of mouse behavior in the non-associative exploratory
task of novel object recognition (NOR) (Lee et al., 2014). We
thus probed memory abilities in Slm2-null mice using this task,
which consisted of exposing them to one previously presented
object (Familiar Object, FO) together with an unfamiliar object
(Novel Object, NO) (Figure 7B). Since mice have innate prefer-
ence toward novelty, prominent NO exploration is an index of
recognition of this object as different from FO. To avoid any
bias in the interpretation of behavioral data due to reduced
exploratory behavior in Slm2 KO mice (Figures 7B–7D), we
measured the preference index for NO (time spent in contact
with NO versus FO), which represents a valuable measure for
increased exploration toward NO regardless of general level of
exploration. Strikingly, Slm2 KO mice showed no increased
interest toward NO (preference index 50%; one-way ANOVA
between genotypes: F,1,18 = 4.24, p = 0.016) (Figure 7E), which
is indicative of impaired recognition memory in Slm2 KO mice.
DISCUSSION
Here, we have sequenced RNA from just the SLM2-expressing
portion of the hippocampus to identify RNA processing path-
ways controlled by this protein. We find that SLM2 auto-regu-
lates, controls an expanded set of alternatively spliced exons
within genes exclusively encoding synaptic proteins, and is
required for normal electrophysiological and behavioral func-
tions. Auto-regulatory pathways have been described for aCell Reports 17, 3269–3280, December 20, 2016 3277
number of splicing regulator proteins where they play an impor-
tant role in splicing factor homeostasis and likely maintain stable
transcriptomes (Jangi and Sharp, 2014), but the physiological
importance of these feedback pathways are not usually well un-
derstood. In contrast, the identification of an SLM2 auto-regula-
tory feedback loop here, along with its other targets being a
restricted group of synaptic protein isoforms, suggests that
SLM2 levels need to be maintained within tight windows for
normal functioning of the nervous system. A similar auto-regula-
tory pathway also controls Sam68, which regulates some of
the same synaptic protein isoforms as SLM2, including the
Neurexin1 and Neurexin3 AS4 exons. Hence, these feedback
pathways were likely present in the ancestral gene that tripli-
cated to give the current SLM2, Sam68, and SLM1 genes. These
feedback pathways would fine-tune expression of these splicing
regulators to ensure stable physiological splicing patterns for the
Neurexin genes, and the maintenance of normal patterns of syn-
aptic connectivity.
Our data also indicate that neurons within the hippocampus
regionally utilize different isoforms generated by alternative
splicing control according to SLM2 protein concentrations.
Electrophysiological measurements of neural network activity
indicate that SLM2 protein levels affect interactions between
electrically coupled pyramidal cells and interneurons (Buzsa´ki
et al., 2013; Traub et al., 2004). In vivo, g oscillations have
been shown to be important for various cognitive tasks such
as working memory (Howard et al., 2003), attention (Fries
et al., 2001), and perception (Gray et al., 1989). Genome
engineering to suppress alternative splicing of the Neurexin3
AS4 exon alone caused reduced excitatory AMPA post-syn-
aptic receptor accumulation, although N-methyl-D-aspartate
(NMDA) receptors remained unchanged (Aoto et al., 2013).
Reduced post-synaptic AMPA receptors would impact upon
the AMPA-mediated phasic drive onto PV interneurons (in
the form of excitatory post-synaptic potentials) that is required
to activate these FS interneurons and their subsequent
phasing of pyramidal cells during g oscillations (Tama´s et al.,
2000; Whittington et al., 1995). Thus, changes in Neurexin
AS4 splicing patterns, which were the highest amplitude
splicing changes detected in the Slm2 KO hippocampus,
could directly influence patterns of g frequency oscillations.
We also detected altered splicing from the CASK gene, which
encodes an important scaffolding trans-membrane protein ki-
nase that interacts with and phosphorylates Neurexin proteins
(Mukherjee et al., 2008). The impaired g-oscillations registered
in the Slm2 KO brain may also be impacted by altered
Tomosyn2 splicing that could affect Tomosyn2 protein stability
(Williams et al., 2011). Tomosyn2 controls acetyl choline
release from cholinergic nerve terminals (Geerts et al., 2015)
and acetylcholine (ACh) is known to induce persistent g-oscil-
lations in the hippocampus (Picciotto et al., 2012). LysoPLD/
ATX encodes one of the major enzymes involved in synthesis
of lysophospatidic acid (LPA), a molecule with a key signaling
role controlling both excitatory and inhibitory synapse func-
tions (Garcı´a-Morales et al., 2015; Vogt et al., 2015). LPA
has a critical role in the nervous system: knockout of LPA1
receptor causes anxiety (Santin et al., 2009), which also char-
acterizes the Slm2 mouse, and LysoPLD/ATX is essential for3278 Cell Reports 17, 3269–3280, December 20, 2016brain development (Greenman et al., 2015). An LPA1-deficient
mouse was also observed to display reductions in g oscilla-
tions, albeit in the entorhinal cortex and not the hippocampus
(Cunningham et al., 2006).
Disruptions in g oscillations within the hippocampus and the
adjacent entorhinal cortex affect forms of learning in which a
novel object has to be stored and later recalled (Lee et al.,
2014), and Slm2-null mice were defective in such novel object
recognition. Our results indicate that proper function of
circuits involved in spatial recognition of novel cues is impaired
in the absence of SLM2. SLM2 protein is widely expressed
across different brain structures, suggesting that its loss might
cause global defects, but Slm2-null mice have no general loco-
motor problems, as assessed in the open-field test, nor in the
rotarod assay. This last test is particularly significant, since
decreased motor coordination can be detected in Sam68-null
mice using a rotarod test (Iijima et al., 2011), indicating a clear
phenotypic difference between these two very similar related
proteins.
EXPERIMENTAL PROCEDURES
RNA-Seq Analysis
Paired-end sequencing was done in total for six samples on an Illumina Hiseq
2000 machine (three biological replicates of wild-type and Slm2 knockout
CA1–CA3 regions. RNA-seq data were mapped using STAR (Dobin et al.,
2013), and splicing changes were analyzed using MAJIQ (Vaquero-Garcia
et al., 2016).
Detection of Splicing Patterns in Mouse Tissues
Alternative mRNA isoforms were measured in total RNA prepared from
different mouse brain structures, using RT-PCR and standard conditions,
with primers provided in Supplemental Experimental Procedures. Reactions
were quantitated by capillary gel electrophoresis and splicing profiles were
calculated as percentage splicing inclusion (PSI).
Generation, RNA Preparation, and PCR from Tetracycline-Inducible
HEK293 Cells
To generate the inducible cell lines, the SLM2-FLAG-pCDNA5 and
Sam68FLAG-pcDNA5 plasmids were individually cotransfected with the Flp
recombinase plasmid (pOG44) into Flp-In HEK293 cells and selected with
Hygromycin B (full details in Supplemental Experimental Procedures).
SLM2-FLAG and SAM68-FLAG were induced by tetracycline. RNA was pre-
pared from the cells at time 0 and 24 hr after tetracycline induction. 24 hr after
tetracycline addition, either 50 mg/mL cycloheximide or ethanol was added to
the cells for 4 hr. cDNA was prepared with Superscript III (Invitrogen) and
DNase-treated RNA.
Minigene Experiments
The Kif21a exon and flanking intron sequences were PCR amplified from
mouse genomic DNA and cloned into pXJ41 (Bourgeois et al., 1999).
Splicing patterns were monitored after transfection into HEK293 cells with
expression constructs encoding GFP, SLM2-GFP, or Sam68-GFP as previ-
ously described (Ehrmann et al., 2013).
Whole-Animal Work
Behavioral assays were carried out according to standard protocols as
described in Supplemental Experimental Procedures.
Immunofluorescence
SLM2 was localized within the mouse hippocampus and entorhinal cortex us-
ing indirect immunofluorescence, according to standard protocols described
in Supplemental Experimental Procedures.
In Vitro Brain Slice Electrophysiology
All procedures were performed according to the requirements of the United
Kingdom Animals Scientific Procedures Act (1986) according to the protocols
described in Supplemental Experimental Procedures.
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